ENTA
ENTA

Enanta Pharmaceuticals Inc

NASDAQ · Biotechnology
$13.51
+0.54 (+4.16%)
Analyst Consensus
Strong Buy
14 analysts
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +229.8% upside
Low Target $33.16
Average Target $44.55
High Target $53.28
Current Price $13.51
Current
$13.51
Target
$44.55
$33.16 $44.55 avg $53.28